Three of the proband's sisters are also RAD51C c.571 + 4A > G heterozygotes, including one diagnosed with BC (invasive lobular carcinoma, clinical stage II) diagnosed at age 48 (PID: II‐3). This evidence concerns the gene RAD51C and invasive lobular breast carcinoma.